VP-4604

Research use only, not for human use.

VP-4604 is a potent anti-methicillin-resistant Staphylococcus aureus (MRSA) compound that exhibited significant microbial growth inhibition against S. aureus with an MIC of 4-8 μg/mL and a growth inhibition rate of over 95%.

VP-4604 is a potent anti-methicillin-resistant Staphylococcus aureus (MRSA) agent. VP-4604 exhibits significant microbial growth inhibition toward Staphylococcus aureus (ATCC 43300) with MIC of 4-8 μg/mL. VP-4604 inhibits the growth of methicillin‐resistant Staphylococcus aureus with growth inhibition >95%.

VP-4604 (2.5 mM, 18 hours) inhibits drug-resistant S. aureus and P. aeruginosa with growth inhibiton (%) GI >95%.VP-4604 shows low cytotoxicity with a CC50 value >118.4 mM towards HEK-293 (human embryonic kidney) ATCC CRL‐1573 and an HC10 vaule >118.4 μM towards RBC (human red blood cells) .VP-4604 (2.5 mM) is tolerated by mammalian cells (HaCaT, lymphocytes) with the inhibition growth (%) of 44.1% and >50%, respectively.Cell Proliferation Assay Cell Line:S. aureus ATCC25923, P. aeruginosa ATCC9027 Concentration:0.625 mM, 1.25 mM, 2.5 mM Incubation Time:18 hours Result: Showed antibacterial effect.Cell Cytotoxicity Assay Cell Line:HaCaT line (human keratinocytes), lymphocytes (from healthy adult human peripheral blood) Concentration:0, 1, 10, 100, 1000, 2500 μM Incubation Time:48 or 72 hours Result:Showed low toxicity towards mammalian cells.

——

——

Microbiology/Virology

Antibiotic

Antibiotic | Antibacterial

——

——

64268-93-5

270.3

C11H14N2O4S

>98% (HPLC)

In Vitro:?DMSO : 25 mg/mL (92.49 mM; Ultrasonic (<60°C)

[O-][N+](=O)c1ccc(cc1)S(=O)(=O)N1CCCCC1

——

(-20℃)

With Ice Pack

≥ 2 years